Adrenal gland neoplasm
MONDO:0021227A neoplasm (disease) that involves the adrenal gland.
Also known as: adrenal gland neoplasm (disease), adrenal gland tumor, adrenal gland tumour, adrenal neoplasm, adrenal neoplasms, adrenal tumor, adrenal tumour, neoplasm of adrenal gland
1576 clinical trials for this condition and its sub-types, 13 tagged with Adrenal gland neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Adrenal gland neoplasm
-
Adrenal cortex neoplasm 11 trials · 63 incl. sub-types
3 sub-types
- Malignant tumor of adrenal cortex 0 trials · 42 incl. sub-types Sub-types →
- Adrenal cortex adenoma 12 trials · 19 incl. sub-types Sub-types →
- Familial hyperaldosteronism type II 0 trials
-
Adrenal gland cancer 16 trials · 62 incl. sub-types
3 sub-types
- Adrenal carcinoma 34 trials · 52 incl. sub-types Sub-types →
- Malignant tumor of adrenal cortex 0 trials · 42 incl. sub-types Sub-types →
- Adrenal medulla cancer 0 trials · 11 incl. sub-types Sub-types →
-
Multiple endocrine neoplasia type 1 34 trials
-
Cushing disease due to pituitary adenoma 23 trials
-
Benign neoplasm of adrenal gland 0 trials · 19 incl. sub-types
3 sub-types
- Adrenal cortex adenoma 12 trials · 19 incl. sub-types Sub-types →
- Adrenal gland myelolipoma 0 trials
- Benign neoplasm of adrenal medulla 0 trials Sub-types →
-
Pheochromocytoma-paraganglioma 18 trials
-
Adrenal medulla neoplasm 0 trials · 16 incl. sub-types
3 sub-types
- Adrenal gland pheochromocytoma 5 trials · 16 incl. sub-types Sub-types →
- Adrenal medulla cancer 0 trials · 11 incl. sub-types Sub-types →
- Benign neoplasm of adrenal medulla 0 trials Sub-types →
Most studied deeper sub-types
-
New hope for liver metastases: immune booster combined with targeted chemo
Disease control Recruiting nowThis study tests whether adding an immune-boosting drug (PDS01ADC) to standard chemotherapy delivered directly to the liver can help people with colorectal, bile duct, or adrenal cancer that has spread to the liver. About 70 adults will receive the drug combination along with a s…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Cancer-Killing virus trial launches for patients out of options
Disease control Recruiting nowThis Phase 1 trial tests IDOV-Immune, a genetically engineered virus designed to infect and destroy cancer cells while boosting the immune system. It is for adults with advanced solid tumors (like colorectal, pancreatic, or lung cancer) that have not responded to standard treatme…
Phase 1 • Sponsor: ViroMissile, Inc. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Promising combo targets Hard-to-Treat childhood cancers
Disease control Recruiting nowThis study is testing a combination of two drugs—a targeted radioactive drug (177Lu-DOTATATE) and a PARP inhibitor (olaparib)—in children and teens aged 3 to 18 with certain solid tumors that have come back or not responded to treatment. The goal is to see if the combination is s…
Phase 1/2 • Sponsor: Fundación de investigación HM • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for rare cancers: immunotherapy drug targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control the tumors when other treatments have stopped working. Up to 28 adults will receive treatment for up to 12 months, an…
Phase 2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Heat therapy via endoscope tested for abdominal tumors
Disease control Recruiting nowThis study tests a procedure called EUS-guided radiofrequency ablation (RFA) for solid tumors in the stomach, liver, kidney, or adrenal glands. It involves using an endoscope to insert a needle that heats and destroys tumor tissue. The study will enroll 30 adults who cannot have …
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
NIH launches study to uncover genetic roots of Hormone-Driven high blood pressure in black communities
Knowledge-focused Recruiting nowThis study aims to find the genetic causes of primary aldosteronism, a condition where adrenal tumors cause high blood pressure, in Black individuals. Researchers will enroll 1150 participants, including those with difficult-to-control blood pressure or known primary aldosteronis…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists dive deep into endocrine tumors to unlock molecular secrets
Knowledge-focused Recruiting nowThis study enrolls people with endocrine tumors (such as thyroid, parathyroid, adrenal, or pancreatic tumors) who are scheduled for surgery or biopsy. Researchers collect samples of the tumor, nearby healthy tissue, blood, and urine to analyze genetic and molecular changes. The g…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists investigate adrenal tumors and seek better therapies
Knowledge-focused Recruiting nowThis study aims to learn more about how adrenal tumors form and to test new treatment options for adrenal cancer. Researchers will study up to 500 adults who have an adrenal tumor seen on imaging. The goal is to improve understanding and find better ways to treat these tumors.
Sponsor: University of Wuerzburg • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Robot vs. laparoscope: which surgery is better for adrenal tumors?
Knowledge-focused Recruiting nowThis study compares two standard keyhole surgeries to remove adrenal gland tumors: laparoscopic and robotic. Researchers want to see which method is faster and leads to better recovery for patients. About 54 adults with adrenal tumors will take part to help improve future care.
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC